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The homograft response to H-Y antigen differs markedly in different strains 
of mice (reviewed by Gasser and Silvers, 1). Females of H-2 b haplotype such as 
C57BL/6 and C57BL/10 (hereafter B6 and B10) regularly reject syngeneic male 
skin, whereas females of most other H-2 haplotypes, so far examined, do not. In 
vitro, the target cell specificity of the secondary cytotoxic response of B10 female 
cells, sensitized to B10 male, is restricted by the H-2 major histocompatibility 
complex (MHC) 1 (2). Furthermore, female responder cells, primed in vivo with a 
syngeneic male skin graft and challenged in vitro in mixed lymphocyte culture 
(MLC) with allogeneic male cells,  fail to lyse syngeneic male target cells (2). 
These observations might be  taken to  indicate that  H-Y  is not detected on 
allogeneic stimulating cells or allogeneic target cells and that H-Y is strain 
specific.  This prompts  us to  publish  data  from our two  laboratories on the 
capacity of allogeneic male skin grafts to sensitize B6 or B10 female mice to 
second grafts of male skin from the same (B6 or B10) strain. Additional data 
demonstrate that B10 females, primed in vivo with allogeneic male skin grafts 
and subsequently challenged in vitro with syngeneic male cells, generate cyto- 
toxic cells specific for syngeneic male target cells. The evidence presented here 
indicates that at least some component of H-Y is detected on allogeneic cells in 
vivo during primary sensitization,  and that the second set cell-mediated re- 
sponse to H-Y is not necessarily restricted by the H-2 haplotype of the sensitiz- 
ing strain. 
Materials and Methods 
Animals.  B6, B6-H-2  ~, A, A.BY, B6-Ly-2  ~ mice were obtained from stocks maintained by E. 
A. Boyse at Memorial Sloan Kettering Cancer Center,  New York.  The congenic B6-Ly-2  a stock 
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Abbreviations  used  in this paper:  A:T, attacking cell to target cell ratio; B6, C57BL/6; B10, 
C57BL/10; FCS, heat-inactivated fetal calf serum; MHC, the H-2 major histocompatability com- 
plex in the mouse; MLC, mixed lymphocyte culture; MST, median survival times; T  (, cytotoxic 
effector T lymphocyte; T H, helper (cooperator) T lymphocyte. 
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used in these experiments was from the eighth backcross generation and differed from B6 by two 
weak histocompatibility loci H(Ly-2-N8) and H(Ly-2-N16) (3, 4). B10.A, A/J, and B10.BR  mice 
were obtained from The Jackson Laboratory, Bar Harbor,  Maine.  Other inbred mice used in 
experiments presented in Tables II-VI were obtained from the Animal Division of the Clinical 
Research Centre, Harrow, Middlesex, England. 
Skin  Grafts.  Body skin  grafts,  1  ×  1.5  cm,  were  grafted to  B6  females as described by 
Billingham (5) with modifications described recently by Wachtel et al. (6). B10 and CBA females 
were grafted with tail skin, 0.5 x 0.5 cm (5). All grafts were scored visually for signs of rejection. In 
experiments with B6 females, 3-6 mo after the first grafts had been rejected, B6 male skin was 
applied to the opposite side of the thorax. In experiments with B10 or CBA female recipients, the 
second male skin grafts were applied to the opposite side of the thorax 1 mo after acute rejection of 
aUogeneic first grafts. Median survival times (MST)  were computed by the graphic method of 
Litchfield (7). Statistical significance was determined by the Wilcoxon rank sum test (8) 
In Vitro Sensitization  and Cytoxicity Assay.  The materials and methods employed for MLC 
and the microcytotoxicity  assay have been previously described (2, 9). Briefly, for MLC, spleen cell 
suspensions from primed B10 females were adjusted to 5 × 106 cells per ml in RPMI medium with 
10% fetal calf serum (FCS). For antigen, a similarly prepared suspension of male spleen cells was 
given 2,000 R from a cobalt 60 source. Responder cells, 10 ml (5 × 107), and irradiated stimulating 
cells, 10 ml (5 × 107), were dispensed into 25 cm  2  plastic tissue culture flasks (Falcon Plastics, Div. 
of Bioquest, Oxnard, Calif.) and incubated, with flasks standing upright, at 37°C in a humidified 
10% CO2 atmosphere. After 5 days, responder cells from the MLC were harvested as a source of 
attacking cells for the microcytotoxicity assay. These cells were adjusted to 2  ×  10  ~ per ml in 
Eagle's minimal essential medium with 10% FCS, and twofold serial dilutions were performed. 0.2 
ml of  each of these attacking cell suspensions was added to wells of a flat-bottomed Microtiter plate 
(Cooke, Division of Dynatech Laboratories, Ltd., BiUingshurst, England) allowing 3 or 4 repli- 
cates for each attacking cell to target cell (A:T) ratio. 0.05 ml (1 x 105) of ~lCr-labeled  concanavalin 
A blast spleen target cells was dispensed into each well. Maximum lysis was determined by adding 
0.05 ml of target cells and 0.2 ml 5% Triton to a  set of wells. Spontaneous release of ~lCr was 
measured from target cells incubated with medium alone. After 5-min centrifugation at 500 rpm, 
plates were incubated for 3 h  at 37°C in a  humidified 10% CO2 atmosphere. Plates were then 
centrifuged at 1,000 rpm for 10 min and 0.1-ml samples of supernate removed for gamma counting. 
The corrected percent lysis was computed according to the formula of Wunderlich et al. (10), and 
linear regression was used for analysis of dose-response data. 
Results 
In  Vivo Second Set Responses  to H-Y.  Responder  female mice,  B6 or B10, 
which  usually  reject  male  skin  grafts,  were  grafted  with  male  donor  skin 
incompatible  for  H-2  and/or  nonoH-2  antigens.  Syngeneic  male  skin  grafts, 
applied after rejection of the first male allografts, were rejected in an accelerated 
manner  (Tables I  and II). The second set response was observed only when first 
grafts were male, not in mice previously ungrafted  or grafted with female skin 
of otherwise  equivalent  genotype.  The effect of male  first grafts from congenic 
H-2  resistant  mice  (e.g.,  B6-H-2  k  and  B10.A)  was  statistically  significant, 
indicating that  at least some component  of H-Y is detected in vivo on primary 
stimulating  cells which  are  incompatible  for H-2  with  the  responder  female. 
However,  A.BY  (H-2 b)  male  grafts  were  more  effective than  A  (H-2 a)  male 
grafts (Table I), and B10.A (H-2  ~) male grafts were more effective than A/J (H- 
2 '~ ) male grafts (Table II). Although both A  and A/J male skin grafts appeared to 
shorten  the  median  survival  time  of subsequent  syngeneic  male  grafts,  the 
effect was not statistically significant. 
Table  III  presents  data  obtained  when  nonresponder  CBA  females  were 
grafted first with allogeneic male skin and then with syngeneic male skin. This 
procedure did not convert these mice to H-Y responders. 812  ALLOGENEIC  SENSITIZATION  TO  H-Y 
TABLE  I 
Survival Times of Male Skin Grafts on B6 Females 
First  skin graR  Survival times of  second (B6 male) skin grafts  (days) 
From:  Histocompatibility differ-  Survival  Individual  values  MST  P 
ences  time (days) 
B6-H-2kd  tl-2  +  H-Y  10-12  11, 13, 13, 15, 15, 17, 18  13.5 
<0.01 
B6-H-2k~  1-1-2  8-11  19, 20, 28, 28, 28, 30, 34, 34, 53, 55  28 
Ad  tt-2  +  non-H-2  +  H-Y  8-12  i0, 14, 14, 18, 26, 28, 32  17 
<0.1 
A  ~  H-2  + non-H-2  9  15, 20, 25, 30, 30, 35, 40, 55  26 
A.BYd*  Non-H-2  +  H-Y  10-14  11, 11, 12, 12, 12, 12, 12, 13, 16  11.5 
<0.01  A.BY9  Non-H-2  10-14  15, 18, 23, 23, 25, 28, 28, 38  22 
B6"Ly-2aC~  Non-H-2  +  H-Y  20-34  10, 10, 10, 10, 11, 11, 11, 12  10 
<0.01 
B6-Ly-2a~  Non-H-2  20-71  11, 15, 16, 18, 20, 23, 28, 28, 38, 38  20 
B6d  H-Y  13-505  9, 9,  10, 11, I1, 12, 15, 16  10.5  <0.015 
* A.BY mice express the H-2  b  phenotype. 
5 MST, 26  days for  42  recipients  grafted in the same week as  the allogeneic  grafts.  Eight of  these females were selected at  random 
for  second set graRs done in parallel  with the allogeneic grafted animals. The survival  times  of  the second graR were compared 
with the survival times of  the  first  graft  for  the eight animals presented here as well as the survival times of  the first  grafts  for  the 
entire group. 
TABLE  II 
Survival Times of Male Skin Grafts on BIO Females 
First skin grafts  Survival times of  second (BI0 male) skin grafts  (days) 
Donor  Histocompatibility differences  Individual values  Median  P 
Bl0c~  H-Y 
BI0?  None 
B10.Ad  H-2  +  H-Y 
B10.A9  H-2 
16, 16, 16, 16, 23, 23, 31, 31, 40+*, 40+  23  0.05  27, 27, 27, 27, 38, 40+, 40+, 40+, 40+, 40+  39 
18, 18, 18, 18, 18, 18, 23, 23, 27, 27  18  <0.01 
23, 27, 31, 88, 38, 40+, 40+, 40+, 40+  38 
A/J~  Non-H-2  + H-2  +  H-Y  16,  16, 18, 23, 23, 27, 27, 31, 31, 31  25  0.1 
A/J~  Non-H-2  + H-2  23, 23, 27, 38, 38, 38, 40+, 40+  38 
A/SAKRc~  Thy 1 +  non-H-2  + H-2  +  H-Y 
AJeAKR~P  Thy 1 +  non-H-2  + H-2 
23, 23, 23, 23, 23, 23, 23, 27, 27, 27, 27, 27  23  <0.01 
27, 27, 27, 31, 31, 38, 38, 38, 38,  40+, 40+, 40+  38 
* Grafts  were not scored from 41 to 59  days  after  grafting.  By 60  days  all  second grafts  had been rejected  by their  female hosts. 
In Vitro Secondary Responses to H-Y.  To determine whether the secondary 
response to H-Y,  after in vivo allogeneic primary sensitization,  is restricted by 
the H-2 complex,  a  series of in vitro secondary sensitizations  and cytotoxicity 
assays was performed. B10 females were primed in vivo by grafting with either 
B10, BALB/c,  or CBA male skin. After 2 or more wk, primed B10 female spleen 
cells were placed in MLC with B10, BALB/c, or CBA male spleen cells for 5 days 
and then assayed against a panel of B10 and BALB/c or CBA male and female 
target cells. The results are given in Table IV. B10 females, primed in vivo and 
challenged  in  vitro  with  B10  male,  gave  the  expected  cytotoxic  response  re- 
stricted  to  B10  male  target  cells.  If primed  and  challenged  with  allogeneic 
(BALB/c or CBA) male, the cytotoxic response was restricted to allogeneic male 
and female target cells (anti-MHC response). However, B10 females, primed in 
vivo with  an allogeneic  (BALB/c  or CBA)  male graft and challenged  in MLC 
with  B10 male  cells,  gave  cytotoxic responses  restricted  to B10 male  targets. 
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Donor 
First  skin  graRs 
Histocompatibility differences 
Survival  times  of  second  (CBA male)  skin  graRs (days) 
Individual values  Median 
CBAc~  H-Y 
CBA9  None 
BI0.BR8  Non-H-2 + H-Y 
BI0.BR@  Non-H-2 
B10.Ad  Non-H-2 +  H-2(K, IA, IB)  +  H-Y 
BI0.A~  Non-H-2  + H-2(K, IA, IB) 
B10d  Non-H-2  + H-2 + H-Y 
B10Q  Non-H-2  + H-2 
I00+, I00+, 100% I00+. I00+, i00+, I00+, I00+ 
I00+, I00+, i00+, I00+, I00+, i00+, I00+, 
i00+,  I00+,  I00+,  I00+,  I00+,  i00+,  100+, I00+, 
i00+, i00+, I00+,  lOOt, 100+, i00+, 100+, 
18, 18, I00+, I00+, I00+, I00+, lOOt,  I00+, i00+, 
I00+,  I00+,  I00+,  I00+,  I00+,  I00+,  i00+, 
100+,  100+,  100+,  100+,  100+,  100+,  100+, 
48, 100+, 100+, 100+,  I00+, 100+,  100+,  100+,  100+, 
100+ 
I00+ 
i00+ 
I00+ 
I00+ 
lOOt 
I00+ 
i00+ 
B10.BR, as shown in Table V. Furthermore, B10 females, primed in vivo with a 
B10.BR female skin graft and challenged in MLC with B10 male, failed to give 
cytotoxic responses to either B10 or B10.BR male or female target cells. Alloge- 
neic presensitization to H-Y, therefore, requires the use of  male cells and is not a 
nonspecific adjuvant effect of allogeneic priming. 
Fi females produced from a responder (B10) parent and a nonresponder (such 
as CBA) parent, when sensitized to a  male of one of the parental haplotypes, 
give cytotoxic responses restricted to that male parental haplotype (11, footnote 
2). Thus, (CBA × B10)F1 females, primed with a CBA male graR and challenged 
in MLC with CBA male cells, will lyse CBA but not B10 male targets. Similarly, 
if primed and challenged with B10 male, the F~ responder cells will lyse B10 
male but not CBA male targets (Table VI). However, if the F1 female is grafted 
with male skin of one parental haplotype (B10 or CBA) and then challenged in 
MLC with male cells of the other parental haplotype (CBA or B10), no cytotoxic- 
ity is seen against either male parental target cell (B10 or CBA), as shown in 
Table VI. 
Discussion 
Previous experimental evidence has indicated that male cells from low re- 
sponder strains and/or allogeneic male grafts can sensitize responder strain 
females to syngeneic male grafts. In an early report of growth inhibition of a 
tumor of male origin,  immunization with cells from males of low responder 
strains,  C3H .and  ST,  was  shown  to  prolong the  survival  of C57BL hybrid 
females subsequently challenged with C57BL male tumor (12). Billingham and 
Silvers (13) demonstrated that bone marrow from males of several low responder 
strains (A, C3H, CBA, and AU) was capable of inducing H-Y-specific tolerance 
in newborn B6 females. It has also been reported that CBA (H-2 k) male lymph 
node cells or male lymph node cells from rats can sensitize B6 females (H-2 b) to 
give a second set response to B6 male skin (14). Finally rejection of B6 or B10 (H- 
2 b) male skin by B6 or B10 females is accelerated by contralateral grai%ing of  rio 
2 k male skin (15, 16). Therefore it is not surprising that allogeneic male skin 
grafts are capable of eliciting a second set response to syngeneic male skin. 
2 Gordon, R. D., L. E. Samelson, and E. Simpson. 1976.  Further studies on the specificity ofT- 
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TABLE  IV 
Specificity of Cell-Mediated Cytotoxic  Responses by BIO ~ Primed with BALB/c d  or 
CBA ~ Skin 
Responding  Antigen  Corrected percent 
cell  Target cell 
In vivo  In vitro  lysis (A:T =  4:1) 
A  B10?  BALB/cd  BALB/cd  B10g  -0.55 ~  0.32 
B10~  1.55 ±  1.32 
BALB/cd  29.90 ±  2.57 
BALB/c?  28.70 ±  2.62 
B10~  BALB/cd  B10d  B10d  20.84  ±  1.46 
B10~  2.26 ± 0.33 
BALB/cd  2.57  ±  0.14 
BALB/c?  1.23  ~  0.13 
B10?  B10d  B10c;  B10g  27.56 ±  1.52 
B10~  2.79  ±  0.37 
BALB/cd  3.70 +_ 0.75 
BALB/c?  2.70 ±  0.13 
B  B10?  CBAd  CBAd  B10d  -1.56 ±  0.80 
B10?  -0.96 ±  0.96 
CBAc~  8.02  ±  1.70 
CBA~  9.62  _  1.05 
B10~  CBAd  B10d  B10~  17.73  ±  1.35 
B10~  0.90 +_  0.76 
CBAd  2.14 ±  0.79 
CBAQ  0.62  ±  0.53 
B109  B10~  B10~  B10g  29.65 ±  2.05 
B109  1.81  ±  1.08 
CBAd  0.78 ±  1.15 
CBA~  2.00 _  0.24 
B10 female spleen cells from mice primed in vivo with a BALB/c, CBA, or B10 male skin graft and 
challenged in vitro with B)/LB/c, CBA, or B10 male spleen cells, were assayed in quadruplicate for 
3 h  with s'Cr-labeled target cells at A:T =  0.5:1,  1:1,  2:1,  and 4:1.  Corrected percent lysis is the 
percent killing of target cells (corrected for background) at A:T =  4:1 as determined from a  four 
point linear regression fit _  1 SE. Background (spontaneous) '~'Cr release was less than 12%, and 
SE were less than 3% of mean counts. 
In Tables I  and II,  male grafts from mice incompatible with the responder 
female for H-2  and/or  non-H-2  antigens  were as effective as syngeneic male 
grafts in their ability to presensitize  B6 or B10 females to a  second syngeneic 
male graft, with the curious exception of A and A/J male first grafts. This might 
be an effect of the more acute first set rejection by B6 and B10 seen with A and A/ 
J  grafts and/or, since B10.A male grafts did presensitize responders to H-Y, this 
might be an effect of non-H-2 antigens in the A  and A/J strains. 
We were unable to convert nonresponder CBA females to responders for H-Y 
by presensitizing  CBA females  with  allogeneic  male  skin  grafts.  A  further 
experiment with a  total of 20 mice,  10 in each group,  indicates that A female 
mice grafted with contralateral  A  male and A.BY male grafts do not reject A GORDON,  MATHIESON,  SAMELSON,  BOYSE~  AND  SIMPSON  815 
TABLE  V 
Specificity of Cell-Mediated Cytotoxic Responses by BIO Q Primed with BI O.BR ~ or 
BIO BR Q Skin 
Responding  Antigen  Corrected percent lysis 
cell  Target cell  (A:T = 4:1) 
In vivo  In vitro 
B10t  B10.BRd  B10.BRd  BlOc7  -3.04 +__  1.00 
B10t  -3.61  -+ 0.61 
B10.BRd  17.38  -+ 0.14 
B10.BRQ  16.49 +-- 0.11 
B10t  B10.BR~  B10d  B10c;  18.42  -+ 2.85 
B10Q  -1.01  -  0.58 
B10.BRd  0.55 +  0.51 
B10.BRQ  0.31  -+  1.30 
B10Q  B10.BRQ  B10.BRd  B10d  -1.46 -+  1.33 
B10?  -1.89 -  0.93 
B10.BRd  24.88 +-- 1.44 
B10.BRQ  25.46 -+ 2.81 
B10Q  B10.BRQ  B10c~  B10c~  -0.32 +- 0.36 
B10Q  -1.61 ±  0.85 
B10.BR~  -0.76 -+ 0.55 
B10.BR?  -0.46 +- 1.31 
B10?  B10d  B10.BRd  B10~  3.06 -+  1.31 
B10Q  1.71  -+ 0.82 
B10.BRc~  44.01  +- 2.93 
B10.BRQ  47.65 -+ 0.41 
B10Q  B10d  B10c~  B10d  57.31  -+  1.09 
B10$  5.20 -+  1.57 
B10 female spleen cells from mice primed in vivo with B10.BR male or female or B10 male skin 
grafts and challenged in vitro with B10.BR or B10 male spleen cells were assayed in triplicate for 3 
h with 5~Cr-labeled target cells at A:T =  1:1, 2:1, 4:1, and 8:1. Corrected percent lysis is the percent 
kill of target cells at A:T  =  4:1  as determined from a  four point linear regression fit  -+  1 SE. 
Background (spontaneous) 51Cr release was less than  13%  and SE  were less than 5%  of mean 
counts. 
male grafts better than A females grafted with contralateral A male grafts.  3 
However, others, using sequential body skin graft timing similar to the experi- 
ments reported here, have reported that allogeneic A.BY or B10 male grafts 
sensitized A females to subsequent A male grafts (17). Since contralateral male 
skin grains have shown different effects than sequential grafts in other H-Y 
reports (see 15, 16) and body skin grafts are more sensitive to rejection than tail 
skin in weak histocompatibility systems including H-Y (4, 18), these results are 
not in conflict. 
In vitro H-2-restricted cell-mediated cytotoxicity was first demonstrated for 
responses to virus-induced and hapten-modified cell surface antigens (reviewed 
by Doherty et al.  and Shearer et al.,  19,  20). To these examples may now be 
added responses to syngeneic fibroblasts (21) and minor H antigens (22, 23), as 
well as H-Y  (2). In nearly all these systems it has been established that F1 
cytotoxic responder cells sensitized to parental cells of one H-2 haplotype will 
lyse only target cells bearing that parental H-2 haplotype at least H-2K or H- 
3 Mathieson, B. J.,  Unpublished observations. 816  ALLOGENEIC  SENSITIZATION  TO  H-Y 
TABLE  VI 
Specificity of Cell-Mediated  Cytotoxic Responses  by (CBA  x BIO)F~  ~ Primed and 
Challenged with CBA ~ and/or BlO~ Cells 
Antigen  Corrected percent 
Responding cell  Target cell 
In vivo  In vitro  lysis (A:T =  4:1) 
(CBA  x  B10)FL~  CBAc;  CBAC;  B10C;  -0.11  ±  0.20 
B10?  0.49  ~-  0.27 
CBAC;  21.73  +  1.38 
CBA¢  5.37  ±  0.30 
(CBA  x  B10)F,9  CBAC;  B10c;  B10C;  1.91  _+  0.62 
B10Q  1.73  ±  0.55 
CBAd  1.10  ±  0.67 
CBA9  3.98  ±  0.43 
(CBA  x  B10)FI?  B10C;  B10C;  B10C;  26.34  ±  2.34 
B10$  2.78  ±  1.02 
CBAd  0.92  ±  1.07 
CBA9  1.89  _  0.20 
(CBA  ×  B10)F~9  B10C;  CBAd  B10C;  -0.59  ±  0.80 
B109  2.86  ±  1.23 
CBAC;  0.55  ±  0.04 
CBA?  1.65  _+  0.33 
(CBA  ×  B10)F, female spleen cells from mice primed  in vivo with a  CBA or B10 male skin graft 
and challenged in vitro with CBA or B10 male spleen cells were assayed in triplicate for 3 h with 
slCr-labeled target cells at A:T =  1:1, 2:1, 4:1,  and 0.5:1  or 6:1.  Corrected percent lysis is the percent 
kill  of target  cells  at  A:T  =  4:1  as determined  from  a  four point  linear  regression  fit  -+1  SE. 
Background  (spontaneous)  s'Cr release  was less than  15%  and  SE  were  less than  5%  of mean 
counts. Maternal parents are listed first in describing the origins ofF, mice, e.g., (CBA ×  B10)F, 
means  (CBA female  ×  B10 male)F. 
2D. As shown in Table VI and as documented more extensively elsewhere (11, 
footnote 2), this has also been shown for T-cell-mediated responses to H-Y. Thus, 
Ho2  compatibility appears to be required between stimulating cell and target 
cell, not just between responder cell and target cell. 
Zinkernagel and Doherty (24) originally proposed  two explanations for Ho2- 
restricted cytotoxicity.  The first hypothesis,  the intimacy or dual recognition 
hypothesis,  requires matching of H-2  determinants on responding T cell  and 
target cell as a prerequisite for recognition of target cell antigen. The second 
hypothesis, the altered-self or interaction hypothesis, postulates recognition of a 
new antigenic determinant or neoantigen resulting from the interaction of self- 
H-2  gene  products  and  the  antigen.  The  finding  that H-2  compatibility  is 
required between stimulating cell and target cell has been interpreted as better 
supporting the altered-self hypothesis, but has not ruled out a dual recognition 
mechanism. 
We here report that responder females,  primed  in vivo with an allogeneic 
male skin graft and challenged  in MLC  with syngeneic  male cells,  generate 
cytotoxic cells able to lyse only syngeneic male cells. In addition, we have found 
that F~ female responders, primed in vivo with one male parental haplotype and 
challenged in MLC with the other male parental haplotype, fail to give cytotoxic 
responses against either male parental target cell.  Allogeneic female cells did 
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immunization, involving stimulating cells of different H-2  haplotypes in pri- 
mary and secondary sensitization,  is  only successful in  generating an  H-Y- 
specific response if (a) the haplotype of the primary stimulating cell in vivo is 
male and alloantigenic to the MHC of the responder, and  (b) the secondary 
stimulating cell in MLC is male and syngeneic with the responder. 
On the basis of present information it is difficult to reconcile these observa- 
tions with either the intimacy or the altered-self  hypothesis. We have been able 
to achieve in vivo primary sensitization of female responder cells to H-Y using a 
male stimulating cell with H-2  haplotype different from the respender cell. 
Thus, primary sensitization to H-Y does not require dual recognition of self-H-2 
determinants and H-Y antigen. Furthermore, F1 females, primed with a skin 
graft bearing one male parental haplotype and challenged in MLC with stimu- 
lating cells bearing the other male parental haplotype, fail to give cytotoxic 
responses against either male parental target cell despite the fact that both 
parental male cells share/-/-2 determinants with the responder cell. 
The altered-self hypothesis predicts that the H-Y antigen for T-cell cytotoxic 
responses is the product of an interaction between H-2 and H-Y gene products 
and is therefore unique for each H-2 haplotype, but this seems inconsistent with 
the observation that it is possible to presensitize female responder cells in vivo 
with male stimulating cells of  H-2 haplotype different from the stimulating cell 
in secondary MLC and target cell in cytotoxicity  assay. Perhaps the stimulating 
cell antigen and the target cell antigen involve different components of H-Y or, 
as has been previously suggested (2), a helper determinant, important during 
primary sensitization, is shared by inbred strains. However, the data demon- 
strating that F1 females, primed with one male parental haplotype and chal- 
lenged in MLC with the other male parental haplotype, fail to generate cyto- 
toxic activity against either male parental haplotype argue against a  shared 
helper determinant. 
It has recently been established that there are several functional subsets of T 
lymphocytes (reviewed by Medawar and Simpson, 25) including cytotoxic effec- 
tor cells  (TC), and cooperator (helper) cells  (TH). The T  n cell is required for 
optimum responses by T  c  cells.  Blanden et al.  (26) have suggested that the 
antigen-receptor dictionaries of these two subsets may be different from each 
other  and  that  in  the  mouse  the  T  c  subset  is  restricted  to  responding  to 
variations in antigenic patterns coded for by H-2K and H-2D region genes, and 
the T  H  cell is restricted to variations in antigenic patterns dictated by genes in 
the H-2I region (Ia antigens?). T-cell responses may be limited to either non-self 
(allogeneic or xenogeneic) MHC antigens or altered-self antigens which result 
from the interaction of self-H-2  antigens and foreign antigens (or a  non-H-2 
gene product such as an H-Y product). This might imply a complex H-Y antigen 
with H-2K/D  and possibly/-/-2/-region determinants. It may be that the T  H 
subset generated during in vivo primary sensitization to non-self (allogeneic) 
male antigen is capable of helping secondary cytotoxic responses to altered-self 
(syngeneic) male antigen by the H-2-restricted T  c cells generated in secondary 
MLC. Thus, H-2 ~ (B10 female) T  n cells generated in vivo in response to H-2(Y) k 
(CBA male) may be able to help subsequent responses by H-2  b (B10 female) T  c 
cells generated in MLC in response to H-2(Y) b (B10 male). We have no definitive 
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observations reported here with the altered-self  hypothesis and has the virtue of 
being amenable to experimental testing. 
The data discussed here do not necessarily conflict with the view that the 
different inbred strains of mice express the same H-Y gene product. Gordon et 
al. (2) have shown that B10 female cells, primed and challenged with B10 male 
cells,  will  lyse F1  targets produced by reciprocal matings of B10  males and 
females with females and males of nonresponder strains (BALB/c, CBA, and A). 
These F1 targets were lysed regardless of whether the H-Y gene was inherited 
from a responder or nonresponder strain male parent and whether the required 
H-2 compatible haplotype (H-2  b) came from a male or female B10 parent. H-2- 
restricted T-cell cytotoxic responses to H-Y can thus be explained on the basis of 
the interaction of an H-Y gene product common to all strains and H-2  gene 
products unique to each strain. The H-Y gene confers the sex specificity and the 
H-2 complex the strain specificity of the response. It is not necessary to invoke 
multiple H-Y alleles to explain strain specificity. 
H-Y antigen has demonstrated a high degree of cross-reactivity serologically, 
not only between inbred strains of mice, but amongst species as well (27, 28). 
The graft rejection data presented as well as the literature discussed above (12- 
16), also supports the concept of cross-reactivity between strains for the homo- 
graft response. Furthermore, Silvers and Yang have demonstrated that in vivo 
xenogeneic sensitization of  female mice with male rat cells results in accelerated 
syngeneic, mouse, male skin rejection (14). It is likely that the antigen-receptor 
dictionary for the B cell is different from that for the T  c cell, and that B cells are 
not restricted to responding to variations in antigenic patterns dictated by MHC 
gene products. Since an in vitro stimulation system requires cells to (a) recog- 
nize a specific antigenic difference (H-Y), (b) survive and proliferate in the MLC 
culture, and (c) subsequently respond as T  c cells in the cytotoxicity assay, this 
highly selected effector population may not reflect the total population of effec- 
tor cells responsible for the  H-Y  in  vivo homograft response.  However this 
highly selected system may allow us to examine the contribution of subsets of 
immunologically reactive cells at specific points in the immune response. 
Summary 
C57BL/6  and C57BL/10 female mice were grafted with skin from male or 
female donors incompatible for H-2  and/or non-H-2 antigens. Syngeneic male 
grafts applied after the rejection of primary allografts or syngeneic male grafts 
were rejected in accelerated (second set) fashion, whereas male grafts applied 
after primary female grains were not. In addition, C57BL/10 female spleen cells, 
primed in vivo with an allogeneic (BALB/c,  CBA,  or B10.BR) male graft and 
challenged in vitro  in mixed lymphocyte culture with syngeneic (C57BL/10) 
male cells, produced cytotoxic cells specific for syngeneic male target cells. 
We  conclude that at  least some component of H-Y  is  detected by female 
responder cells on allogeneic male cells, and that the second set cell mediated 
response to H-Y is not necessarily  restricted by the H-2 haplotype of  the primary 
sensitizing strain. Moreover, (CBA x B10) F1 females, primed in vivo with male 
cells of one parental haplotype (B10 or CBA) and challenged in vitro with male 
cells of the other parental haplotype (CBA or B10), fail to lyse male target cells 
of either parental haplotype. It therefore seems unlikely that a helper determi- GORDON,  MATHIESON,  SAMELSON,  BOYSE,  AND  SIMPSON  819 
nant shared between B10 and CBA is sufficient to explain the ability of CBA 
male cells to prime H-2-restricted T-cell cytotoxic responses by B10 females. 
Received for publication 19 May 1976. 
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